1 / 59

Laboratory Investigations – all that a blood banker needs to Know

Laboratory Investigations – all that a blood banker needs to Know. Department of Clinical Pathology & Blood Bank C M C Vellore India. Tests for Appropriate use of :-. Red Cells Platelets Plasma Cryo Factor Concentrate By pass agents – rFVIIa/ FEIBA Others – Tranexamic acid, DDAVP.

arella
Download Presentation

Laboratory Investigations – all that a blood banker needs to Know

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Laboratory Investigations – all that a blood banker needs to Know Department of Clinical Pathology & Blood Bank C M C Vellore India

  2. Tests for Appropriate use of :- • Red Cells • Platelets • Plasma • Cryo • Factor Concentrate • By pass agents – rFVIIa/ FEIBA • Others – Tranexamic acid, DDAVP

  3. Red Cells and Platelets • Hb/ PCV/ RCC • Platelet count

  4. The Coulter Principle

  5. A red cell passes through RBC aperture Red Blood Cell Sensing Zone Ohm’s law: Voltage = Current X resistance Oscilloscope Oscilloscope

  6. A White cell passes through WBC aperture Neutrophil Oscilloscope Sensing Zone Thresholds for sensing the voltage can be adjusted Oscilloscope

  7. Applying Thresholds to separate Plt from RBC 20 fl 2 fl Base line Platelets RBC of various sizes

  8. Platelet count and Platelet morphology and numbers on smear • Manual or Machine

  9. Platelet Histogram

  10. Laboratory Evaluation of Haemostasis

  11. Screening Tests for Hemostasis • Platelet count • Bleeding time (BT) - Plt adh-vWF,Gp1b/ Plt aggr- GpIIb-IIIa/ Plt secretion • Prothrombin time (PT) - Extrinsic pathway factors-VII,V,X,II and Fibrinogen • Activated Partial thromboplastin time (aPTT) – Intrinsic pathway factors XII,XI,IX,VIII,V,X,II,Fibrinogen • Most important is - History

  12. Value of history in Diagnosis An abnormal coagulation parameter has no major diagnostic value if the patient • is not bleeding • has not been a bleeder ( no past history of bleeding) • not likely to be a bleeder –( no family or medication history)

  13. History • Key to understanding and diagnosing hemorrhagic disorders * Without any symptoms an abnormal coagulation test result has no value * With a good history you may just need basic tests of haemostasis in the laboratory for diagnosis

  14. Bleeding Time • Time taken by a standardized skin wound to stop bleeding • Standard Skin wound – 2.5 to 3 mm deep and 1.0 to 1.5 mm wide (Ivy’s Method) • Lancet tip is 3 mm long and 1.5 mm wide at the base

  15. Bleeding Time (Modified Ivy’s Method) • BP cuff to 40 mm Hg • Select an area avoiding any vein or angiomas • Clean the Volar aspect • Stab confidently three times and start Stop watch at the end of the third wound. • At least one wound is STANDARD

  16. Results of Bleeding Time • Stop the Stopwatch when all the wounds stops bleeding • Normal – 2 to 6 minutes • Ideal to establish your own range • Prolongation – a) Vascular defect b) Adhesion Defect – VWF (Von Willebrand disease) or Platelet adhesion molecule Gp1b (Bernard Soulier Syndrome) c) Aggregation defect – Platelet aggregation receptors GpIIbIIIa (Glanzmann Thrombasthenia) d) Platelet Secretion Defect – Platelet Granule deficiency (Gray platelet) or Aspirin

  17. Interpretation and further Specific Tests - Von Willebrand Factor assays - Platelet Aggregometry studies - Clot Retraction – absent in aggregation defects

  18. Tests for Secondary haemostatic Factor defects - • All these Factors are present in the plasma • Tests for Clotting factors - plasma based tests • Important – care in preparing plasma • Starts at Blood sampling • Avoid contamination by Tissue and avoid activation

  19. Preparing plasma • Anticoagulate blood in Trisodium Citrate to prevent clotting of blood to be tested by chelating Calcium. One part Citrate and nine part Blood from veins • Carefully collected to prevent activation of factors • Two syringe method- 1st for blood counts and 2nd for Coagulation studies

  20. Preparing Plasma • Centrifuge at high speed (1500 – 2000g for 10 min) - To separate • Plasma as Platelet Poor Plasma • Test immediately before less stable factors are lost. • If not keep in ice bath

  21. Plasma Based Tests • All clotting tests to be done in a 370C water bath. A circulating water bath is ideal. • Keep test plasma or control plasma and reagents at 370C at least 5 min before doing the tests

  22. Activators

  23. Plasma Based Tests – Adding the activator

  24. Timing

  25. Automated Coagulometers

  26. CMC-EQAS

  27. Prothrombin Time • Time taken by a recalcified citrated plasma to clot in presence of Tissue Factor. • Tests the Extrinsic Pathway – Tissue Factor will activate the extrinsic pathway by activating FVII onwards • Tissue Factor - Thromboplastin with its bound negatively charged phospholipid

  28. Results • Normal Range – 9 to 12 seconds or 12-15 seconds (Depending on the Reagent) RESULTING • Raw Data- Patient time and Reference range. • Prothrombin ratio (PR) = Patient time Control time • >1.2 (3 Seconds more than Control) Prolonged PT indicates deficiency of FVII, FX, FV, FII and Fibrinogen

  29. Factors affecting - PT Result • Variety of reagents (containing different thromboplastin) are available in the market some are good and some are bad giving different PR (Prothrombin Ratio) on the same sample. • Ideally a good screening test reagent should be very sensitive so that all levels of low factors can be picked up when a PT is done.

  30. Sensitivity of a PT reagent • Most sensitive PT reagent – picks up the mildest of deficiency and exaggerates the difference between ranges of deficiency.( PT is abnormal even if FVII is 40% and there is a significant difference in PT time when levels are 13% and 17%) • Least sensitive PT reagent- misses deficiency and will not show the difference between ranges of deficiency .( PT is normal even if FVII is 23% and there is no significant difference in PT time when levels are 11% and 17%)- BAD Reagent

  31. PT Result - ISI and INR • International sensitivity index (ISI)- value that is assigned indicating the sensitivity of the reagent. • Most sensitive reagent has ISI close to a value of 1 • Less sensitive reagents will be more than 1.4 onwards • International normalized ratio (INR) is normalizing a PT expressed as PR by incorporating the allocated sensitivity (ISI) of the PT reagent used = PRISI

  32. aPTT • Time taken by a recalcified citrated plasma to clot in presence of negatively charged - contactactivator (Silica, Kaolin, Ellagic acid) - phospholipid (Partial Thromboplastin) • Tests the Intrinsic Pathway - Contact activator will activate the intrinsic pathway by activating FXII onwards with the help of phospholipids

  33. Results • Normal range – 27 – 37 Seconds (Different for different Reagents) Resulting • Raw Data- Patient time and Reference range • Ratio ->1.2 (more than 6 secs difference from the Control time) Prolonged aPTT indicates deficiency of FXII, FXI, FIX, FVIII, FX, FV, FII and Fibrinogen

  34. Results • What next If results are abnormal (Prolonged time) • Prolonged aPTT indicates deficiency of FXII, FXI, FIX, FVIII, FX, FV, FII and Fibrinogen • Prolonged PT indicates deficiency of FVII, FX, FV, FII and Fibrinogen • A Thrombin time is done since it picks Fibrinogen deficiency. Time taken by plasma to clot when thrombin is added – this is the time taken by thrombin to convert F’gen to Fibrin.

  35. Mixing/Correction Studies • Done when PT/APTT are prolonged • Mixing studies :- Mix equal volumes of test (abnormal) plasma and control pool plasma (where all factors are present in normal quantity) and repeat the test. • Rationale: - if the prolongation in time is due to deficiency of factor (s) in the test plasma, normal plasma will provide the deficient factor when they are mixed correcting the prolonged time - if the prolongation in time is due to an inhibitor (antibody to factor or heparin) the normal plasma will also be inhibited and the prolonged time will remain prolonged • Correction of time: Deficiency of factor • No correction: Inhibitor

  36. No correction • Whatever caused the abnormal (prolonged) timing is also causing an abnormality to normal plasma after the patients plasma was mixed in it. - Heparin - Lupus anticoagulant (antiphospholipid antibody) - Factor Inhibitor ( antibodies to Clotting factors) - FDP/D-Dimer

  37. Correction Studies • Direct interpretation to therapy • Patient who is bleeding with a prolongation in plasma clotting tests • Correction of the time by mixing studies in which the normal plasmasupplied the deficient factor will directly mean that if you give (transfuse) the patient - normal plasma (FFP) his clotting defect, that lead to the prolongation of the time, will get corrected and the bleeding will stop. • Non Correction of time – No benefit of transfusing FFP. Use safer products • Heparin – use Protamin • Inhibitor – other agents • Standard Mixing studies – will miss a FVIII inhibitor

  38. FVIII inhibitor • Late acting • Picked only on incubation , for e.g, Patient – aPTT = 120 sec Control = 30 sec Mixing = 40 sec (Keep the “Mix” and individual plasmas 2 hours in water bath) aPTT of Incubated Mix = 102 sec

  39. Definitive (Specific) Tests • Specific Factor assays • Inhibitor assay

  40. Quantify Inhibitors – Bethesda Assay • Quantify the amount of inhibitors • Principle of the assay - Ability of a patients plasma to neutralize FVIII in normal plasma (Plasma ≈ 100% FVIII) • on mixing and incubating for 2 hrs • Bethesda Units • <5 BU low responder • Treatment

  41. Urea clot solubility(Qualitative assay for FXIII) • Fibrin is held by weak forces till FXIII introduces bonds between them. Weak forces will dissolve in low ionic strength solution but not the strong bonds. • Weak ionic strength solution is – 5 Molar Urea • Incubate clot in 5M Urea overnight. • FXIII deficiency- no clot seen the next day (the clot dissolves) but the clot in a normal plasma appears the same.

  42. Are these tests Useful ? • Issues:- - Availability - Reliability - Fasterturn around time (TAT) Limitation exists for FFP/Cryo (These tests are necessary in blood banks with components for use in ensuring quality control of these products – Coag Factor assays etc)

  43. Any Alternative • At least start with Red cells and Platelets - Hb/Hct - Platelet count - Reliability - Faster TAT - Quality Assurance as per ISO-15189 NABL • Look at alternative POC/ NPT (Point of Care/ Near Patient Testing) devices – • ROTEM/TEG - Thromboelastography

  44. Thromboelastography (ROTEM/TEG)--------- Stationary cup with blood - oscillated ( 4o to45’ -10 secs) Pin is suspended - torsion wire - monitored for motion. Measure the torque of rotation - transmitted from the immersed pin – after fibrin platelet bonding has linked the cup and pin together Clot activation by TF (at Physiological level) CT/R- Clot time Rate of Clotting – CFT/k and α angle – rate of thrombin generation MA/MCF – Clot strength (Plt/Fib)

  45. Normal TEG

  46. Thromboelastogram TEG (Whole Blood) 10% 1% 20% 2% 30% 0.5% 5% 0.2% FVIII deficient blood spiked with Recombinate

More Related